KR Choksey Lists Large Cap, Midcap, & Small Cap Stocks As Top Picks, Suggests Buy For Upto 40% Gains

Leading brokerage firm KR Choksey in its "April Top Ideas Picks" lists large-cap, midcap and small-cap stock from the various sectors as the top picks. The brokerage places "Buy" on the stocks with attractive target prices, and claims strong returns of up to 40% from their current market price. Check below to know more:

Asian Paints Ltd. (APNT)

KR Choksey suggests "Buy" APNT with a target price of Rs 3,564/share, claiming a potential upside of up to 29% upside. The last traded share price of APNT is Rs 2,777/share. Its 52 week high is Rs 3,582.90/share and 52 week low is Rs 2,560/share, respectively.

It has given 0.95% negative return in the past 1 week, and 10.83% in the past 1 year, respectively. It has given 82.59% positive return in the past 3 years, and 141.04% in the past 5 years, respectively. It is a large-cap building material sector stock having a market capitalisation of Rs 2,66,369 crore.

KR Choksey said, "We expect revenue/ EBITDA/ Adj. PAT to grow at 15.9%/ 24.2%/ 25.5% CAGR, respectively, between FY22-25E. We apply a P/E multiple of 55.0x on FY25E EPS of INR 64.8 to arrive at a target price of INR 3,564, an upside potential of 28.3%. Accordingly, we maintain our "BUY" rating on the shares of Asian Paints Ltd."

Rossari Biotech Ltd (RBL)

KR Choksey recommends "Buy" on RBL for gains upto 25% with an estimated target price of Rs 747/share. The last traded share price is Rs 602.30/share on NSE. It recorded 52 week high is Rs 1,052.85/share and 52 week low is Rs 536.35/share, respectively.

Since its listing on 23rd July 2020 its share value falls 18.79%. However, in the past 1 week, it gains 1.98%. In the past 1 year, it falls 17.04% and in the past 3 years, it falls 36.53%. The stock operates in the Chemicals sector. It is a small-cap stock with a market valuation of Rs 3,321.80 crore.

KR Choksey said, "Currently, the stock is trading at a PE multiples of 27.2x / 18.5x based on our FY23E / FY24E EPS respectively. We estimate PAT to grow at 35.5% CAGR over FY22-24E with EBITDA margin range of 13.5% - 15%. We expect target price of INR 747/share within 6 months (P/E multiple 23x to FY24 EPS) and retain our BUY recommendation on the stock (upside: 24%)."

CreditAccess Grameen Ltd. (CREDAG)

KR Choksey recommends "Buy" on CREDAG with an estimated target price of Rs 1,290/share. With the given target price, the stock can fetch up to 40% gains. The stock last traded at Rs 926.15/share. Its 52 week high is Rs 1,154/share and 52 week low is Rs 834.10/share, respectively.

The stock surges 3.12% in the past 1 week. Whereas in the past 1 year, it gave 5.53% positive return. In the past 3 years, it gave 188.3% positive return, respectively. It is a large-cap building material sector stock having a market capitalisation of Rs 2,66,369 crore. It is an NBFC sector midcap stock having a market capitalisation of Rs 14,463.75 crore.

KR Choksey said, "Currently, the stock is trading at P/ABV multiples of 3.0x/2.5x/2.0x based on FY23E/FY24E/25E ABVPS. We assign P/ABV multiple 2.8x to FY25E ABVPS of INR 461 to arrive at our target price of INR 1,290/share with an upside of 40.2% over the CMP. Accordingly, we maintain our "BUY" rating on CREDAG."

Disclaimer - The stocks have been picked from the brokerage report of KR Choksey. Greynium Information Technologies, the Author, and the respective Brokerage house are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to consult with certified experts before making any investment decision.